| scholarly article | Q13442814 |
| P50 | author | Thomas W. White | Q42427523 |
| P2093 | author name string | Noah A Levit | |
| P2860 | cites work | Severe form of keratitis-ichthyosis-deafness (KID) syndrome associated with septic complications | Q84567570 |
| Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironment | Q84756817 | ||
| Keratitis-ichthyosis-deafness syndrome: response to alitretinoin and review of literature | Q84772346 | ||
| Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response | Q24543614 | ||
| Quinine blocks specific gap junction channel subtypes | Q24555201 | ||
| Bulk isolation of mouse hepatocyte gap junctions. Characterization of the principal protein, connexin | Q24682351 | ||
| Hexagonal array of subunits in intercellular junctions of the mouse heart and liver | Q24682840 | ||
| The role of connexins in ear and skin physiology - functional insights from disease-associated mutations | Q26827294 | ||
| Aberrant Cx26 hemichannels and keratitis-ichthyosis-deafness syndrome: insights into syndromic hearing loss | Q27002992 | ||
| Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43. | Q27320878 | ||
| Functional studies of human skin disease- and deafness-associated connexin 30 mutations | Q28213840 | ||
| Gap junctions and cochlear homeostasis | Q28245955 | ||
| The skin: an indispensable barrier | Q28302280 | ||
| Electrophysiology of single and aggregate Cx43 hemichannels | Q28484555 | ||
| Connexin46, a novel lens gap junction protein, induces voltage-gated currents in nonjunctional plasma membrane of Xenopus oocytes | Q28568971 | ||
| The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome | Q30428153 | ||
| Inhibition of CD44 gene expression in human skin models, using self-delivery short interfering RNA administered by dissolvable microneedle arrays | Q30524055 | ||
| Beyond the gap: functions of unpaired connexon channels | Q33186594 | ||
| Connexins regulate calcium signaling by controlling ATP release | Q33610043 | ||
| Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms | Q33756712 | ||
| Connexins: a connection with the skin | Q33895160 | ||
| Differentially altered Ca2+ regulation and Ca2+ permeability in Cx26 hemichannels formed by the A40V and G45E mutations that cause keratitis ichthyosis deafness syndrome | Q33950693 | ||
| Gap junctions. | Q34020827 | ||
| Mutations in connexin genes and disease | Q34137935 | ||
| Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors | Q34179601 | ||
| Pathogenic connexin-31 forms constitutively active hemichannels to promote necrotic cell death | Q34185915 | ||
| The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities | Q34186774 | ||
| Ion channels are linked to differentiation in keratinocytes | Q34306165 | ||
| Connexin mimetic peptides: specific inhibitors of gap-junctional intercellular communication | Q34332523 | ||
| Connexins and cell signaling in development and disease | Q34357394 | ||
| Connexon-mediated cell adhesion drives microtissue self-assembly | Q34421753 | ||
| Wounding alters epidermal connexin expression and gap junction-mediated intercellular communication | Q34452878 | ||
| Extracellular calcium-dependent regulation of transmembrane calcium fluxes in murine keratinocytes | Q34491301 | ||
| Abnormal connexin expression underlies delayed wound healing in diabetic skin. | Q34667089 | ||
| The effect of a connexin43-based Peptide on the healing of chronic venous leg ulcers: a multicenter, randomized trial | Q34727748 | ||
| Prospects for rational development of pharmacological gap junction channel blockers | Q35007602 | ||
| Switch in gap junction protein expression is associated with selective changes in junctional permeability during keratinocyte differentiation | Q35575333 | ||
| Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia | Q35602775 | ||
| An update on connexin genes and their nomenclature in mouse and man. | Q35609932 | ||
| Visualization of plasmid delivery to keratinocytes in mouse and human epidermis | Q35619666 | ||
| Mechanism of inhibition of connexin channels by the quinine derivative N-benzylquininium | Q35647366 | ||
| Inhibition of connexin 43 hemichannel-mediated ATP release attenuates early inflammation during the foreign body response | Q35667353 | ||
| Connexin 43 deficiency accelerates skin wound healing and extracellular matrix remodeling in mice. | Q35668477 | ||
| Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial | Q35756192 | ||
| Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome | Q35764888 | ||
| Connexins: functions without junctions | Q35885621 | ||
| Gap junction diseases of the skin | Q35910651 | ||
| CASK (LIN2) interacts with Cx43 in wounded skin and their coexpression affects cell migration | Q36010026 | ||
| Gap junctional communication in tissue inflammation and repair. | Q36162602 | ||
| Local delivery of gene-modifying triplex-forming molecules to the epidermis | Q36494745 | ||
| Keratitis-ichthyosis-deafness syndrome: disease expression and spectrum of connexin 26 (GJB2) mutations in 14 patients. | Q36768312 | ||
| Connexin 43 hemichannels are permeable to ATP. | Q36803018 | ||
| Connexin mimetic peptides inhibit Cx43 hemichannel opening triggered by voltage and intracellular Ca2+ elevation | Q36870663 | ||
| The human Cx26-D50A and Cx26-A88V mutations causing keratitis-ichthyosis-deafness syndrome display increased hemichannel activity | Q36923559 | ||
| The D50N mutation and syndromic deafness: altered Cx26 hemichannel properties caused by effects on the pore and intersubunit interactions | Q36951959 | ||
| Connexons and cell adhesion: a romantic phase | Q37164105 | ||
| Potent block of Cx36 and Cx50 gap junction channels by mefloquine | Q37485123 | ||
| Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in vivo | Q37488508 | ||
| Involvement of gap junction channels in the pathophysiology of migraine with aura | Q37601409 | ||
| Malignant skin tumours in patients with inherited ichthyosis | Q37868636 | ||
| Modulation of connexin signaling by bacterial pathogens and their toxins | Q37886840 | ||
| Connexins in epidermal homeostasis and skin disease. | Q37935969 | ||
| Connexins in wound healing; perspectives in diabetic patients. | Q37966550 | ||
| Purinergic signaling in healthy and diseased skin | Q37967105 | ||
| GJB2 Gene Mutations in Syndromic Skin Diseases with Sensorineural Hearing Loss | Q38006692 | ||
| Keratitis, ichthyosis, and deafness syndrome: a review of infectious and neoplastic complications | Q38079354 | ||
| Connexin channel modulators and their mechanisms of action | Q38099907 | ||
| Successful treatment with alitretinoin of dissecting cellulitis of the scalp in keratitis-ichthyosis-deafness syndrome | Q43611080 | ||
| Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels | Q43854350 | ||
| Retinoids inhibit squamous cell carcinoma growth and intercellular communication | Q43939537 | ||
| KID syndrome: response to acitretin | Q44134571 | ||
| Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid | Q44325495 | ||
| Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity | Q44948884 | ||
| A novel connexin 26 gene mutation associated with features of the keratitis-ichthyosis-deafness syndrome and the follicular occlusion triad | Q45037252 | ||
| KID syndrome. | Q46719371 | ||
| Healing refractory venous ulcers: new treatments offer hope | Q47574946 | ||
| Connexins 26, 30, and 43: differences among spontaneous, chronic, and accelerated human wound healing | Q47613086 | ||
| Connexin mutations causing skin disease and deafness increase hemichannel activity and cell death when expressed in Xenopus oocytes. | Q48735734 | ||
| Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness | Q48795296 | ||
| The Clouston syndrome mutation connexin30 A88V leads to hyperproliferation of sebaceous glands and hearing impairments in mice | Q50425772 | ||
| The connexin26 S17F mouse mutant represents a model for the human hereditary keratitis-ichthyosis-deafness syndrome | Q50436327 | ||
| A novel mutation in the connexin 26 gene (GJB2) in a child with clinical and histological features of keratitis-ichthyosis-deafness (KID) syndrome | Q50436542 | ||
| Germline mosaicism in keratitis-ichthyosis-deafness syndrome: pre-natal diagnosis in a familial lethal form | Q50438243 | ||
| Connexin 26 (GJB2) mutations in two Swedish patients with atypical Vohwinkel (mutilating keratoderma plus deafness) and KID syndrome both extensively treated with acitretin. | Q50460646 | ||
| Ocular manifestations of keratitis-ichthyosis-deafness (KID) syndrome. | Q50475059 | ||
| Hereditary palmoplantar keratodermas. | Q51739214 | ||
| Connexin mimetic peptides improve cell migration rates of human epidermal keratinocytes and dermal fibroblasts in vitro. | Q51751372 | ||
| Dynamic changes in connexin expression correlate with key events in the wound healing process. | Q52103296 | ||
| Melanocytic tumors express connexin 43 but not 26: immunohistochemical analysis with potential significance in melanocytic oncogenesis. | Q53123297 | ||
| Palmoplantar keratosis in oculodentodigital dysplasia with a GJA1 point mutation out of the C-terminal region of connexin 43. | Q54243374 | ||
| Hemi-gap-junction channels in solitary horizontal cells of the catfish retina. | Q54280754 | ||
| Exome sequencing reveals mutation in GJA1 as a cause of keratoderma-hypotrichosis-leukonychia totalis syndrome | Q55671532 | ||
| A familial case of Keratitis-Ichthyosis-Deafness (KID) syndrome with the GJB2 mutation G45E | Q57554998 | ||
| GJB2mutations in keratitis-ichthyosis-deafness syndrome including its fatal form | Q57637012 | ||
| The G60S Cx43 mutant enhances keratinocyte proliferation and differentiation | Q57921889 | ||
| The G60S connexin43 mutant regulates hair growth and hair fiber morphology in a mouse model of human oculodentodigital dysplasia | Q57922088 | ||
| Targeted epidermal expression of mutant Connexin 26(D66H) mimics true Vohwinkel syndrome and provides a model for the pathogenesis of dominant connexin disorders | Q57962398 | ||
| Malignant proliferating pilar tumors arising in KID syndrome: A report of two patients | Q60607682 | ||
| Keratitis, ichthyosis, and deafness (KID) syndrome. Vertical transmission and death from multiple squamous cell carcinomas | Q69012411 | ||
| Keratitis, ichthyosis, and deafness syndrome with development of multiple cutaneous neoplasms | Q69588243 | ||
| Fatal keratitis ichthyosis and deafness syndrome (KIDS). Aural, ocular, and cutaneous histopathology | Q70564474 | ||
| The Keratitis, Ichthyosis, and Deafness (KID) Syndrome | Q70752062 | ||
| Carcinoma of the tongue in a child: report of case | Q70965913 | ||
| Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasia | Q71724831 | ||
| Identification of aberrantly regulated genes in diseased skin using the cDNA differential display technique | Q73012081 | ||
| Selective permeability of different connexin channels to the second messenger inositol 1,4,5-trisphosphate | Q73566630 | ||
| Keratitis-ichthyosis-deafness (KID) syndrome with squamous cell carcinoma | Q80176477 | ||
| The connexin31 F137L mutant mouse as a model for the human skin disease erythrokeratodermia variabilis (EKV) | Q80186632 | ||
| Connexin 30, a new marker of hyperproliferative epidermis | Q80241349 | ||
| Severe ichthyosis-related disorders in children: response to acitretin | Q80372269 | ||
| Gene expression profiling of porokeratosis demonstrates similarities with psoriasis | Q80877205 | ||
| Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad | Q81235567 | ||
| Connexin disorders of the skin | Q81396454 | ||
| Connexin 26 (GJB2) mutations in keratitis-ichthyosis-deafness syndrome presenting with squamous cell carcinoma | Q82584877 | ||
| Porokeratotic eccrine duct and hair follicle nevus (PEHFN) associated with keratitis-ichthyosis-deafness (KID) syndrome | Q83017872 | ||
| Gap26, a connexin mimetic peptide, inhibits currents carried by connexin43 hemichannels and gap junction channels | Q83618373 | ||
| Gap junction remodeling in skin repair following wounding and disease | Q38103438 | ||
| The use of connexin-based therapeutic approaches to target inflammatory diseases. | Q38136917 | ||
| Tonabersat for migraine prophylaxis: a systematic review | Q38180993 | ||
| Connexins: sensors of epidermal integrity that are therapeutic targets | Q38194341 | ||
| Mechanisms linking connexin mutations to human diseases | Q38268356 | ||
| Treatment of keratitis-ichthyosis- deafness (KID) syndrome in children: a case report and review of the literature | Q38302587 | ||
| Connexins and skin disease: insights into the role of beta connexins in skin homeostasis. | Q38330396 | ||
| Oral squamous cell carcinoma in a patient with keratitis-ichthyosis-deafness syndrome: a rare case | Q38373036 | ||
| Effect of enhanced expression of connexin 43 on sunitinib-induced cytotoxicity in mesothelioma cells | Q38871697 | ||
| Gap junctions modulate glioma invasion by direct transfer of microRNA | Q38874498 | ||
| Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis. | Q39340613 | ||
| Peptidoglycan derived from Staphylococcus epidermidis induces Connexin43 hemichannel activity with consequences on the innate immune response in endothelial cells | Q39659848 | ||
| Squamous cell carcinoma in congenital ichthyosis with deafness and keratitis. A case report and review of the literature | Q39853888 | ||
| Role for connexin 26 in metastasis of human malignant melanoma: communication between melanoma and endothelial cells via connexin 26. | Q40110789 | ||
| Erythrokeratodermia variabilis et progressiva allelic to oculo-dento-digital dysplasia | Q40279394 | ||
| Selective permeability of different connexin channels to the second messenger cyclic AMP. | Q40337052 | ||
| Selective transfer of endogenous metabolites through gap junctions composed of different connexins | Q40916863 | ||
| Connections with connexins: the molecular basis of direct intercellular signaling | Q41006464 | ||
| The expression of the gap junctional protein Cx43 is restricted to proliferating and non differentiated normal and transformed keratinocytes | Q41096131 | ||
| Aberrant connexin26 hemichannels underlying keratitis-ichthyosis-deafness syndrome are potently inhibited by mefloquine | Q41946636 | ||
| Altered connexin expression and wound healing in the epidermis of connexin-deficient mice | Q42444130 | ||
| Upregulation of connexin 26 between keratinocytes of psoriatic lesions | Q42458196 | ||
| Upregulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium | Q42469355 | ||
| Topography of mammalian connexins in human skin | Q42476250 | ||
| Differential induction of connexins 26 and 30 in skin tumors and their adjacent epidermis | Q42481789 | ||
| Differential expression of connexins during stratification of human keratinocytes | Q42492241 | ||
| Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion | Q42500654 | ||
| A murine living skin equivalent amenable to live-cell imaging: analysis of the roles of connexins in the epidermis | Q42520745 | ||
| Modulations in epidermal calcium regulate the expression of differentiation-specific markers | Q42528076 | ||
| In vivo modulation of connexins 43 and 26 of human epidermis by topical retinoic acid treatment | Q42547863 | ||
| A novel mechanism for connexin 26 mutation linked deafness: cell death caused by leaky gap junction hemichannels | Q42605336 | ||
| Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. | Q42832944 | ||
| Tonabersat: a cortical spreading depression inhibitor as potential pharmacologic prophylaxis in migraine with aura | Q43083040 | ||
| P304 | page(s) | 337-343 | |
| P577 | publication date | 2015-07-23 | |
| P1433 | published in | Pharmacological Research | Q15724622 |
| P1476 | title | Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases | |
| P478 | volume | 99 |
| Q42315386 | Altered CO2 sensitivity of connexin26 mutant hemichannels in vitro |
| Q38888995 | Connexins and their channels in inflammation |
| Q38761884 | Erythrokeratodermia variabilis et progressiva |
| Q38862310 | Specific functional pathologies of Cx43 mutations associated with oculodentodigital dysplasia |
| Q42387224 | Structural studies of N-terminal mutants of Connexin 26 and Connexin 32 using (1)H NMR spectroscopy |
| Q39093592 | The role of gap junctions in inflammatory and neoplastic disorders (Review). |
Search more.